In patients with ccRCC from TCGA database, we observed that DRD2 expression was positively correlated with GLI1, OCT4, and Nanog expressions (Fig. 7F) and poor prognoses of patients (Fig. 7G). The gene discussed is DRD2; the disease is nonpapillary renal cell carcinoma.